ERBB2 and breast carcinoma: Delphinidin inhibited proliferation, blocked anchorage-independent growth, and induced apoptosis in ER-positive, triple-negative, and HER2-overexpressing breast cancer cell lines while causing minimal harm to non-transformed breast epithelial cells.